| News
BioFi AG newly settles in Basel
15.08.2022
BioFi has set up its headquarters in Basel. The company has emerged from Crowley Davis Research, which was established in the US state of Idaho in 2000. Using its proprietary technologies, BioFi operates the CellSim platform, which can be used to model and simulate living organisms.
The newly established company BioFi AG has settled in Basel. It brings with it the technological heritage of US company Crowley Davis Research Inc, which is being dissolved, and operates a proprietary, trademarked platform called CellSim. This provides virtual modeling and simulation solutions for living organisms, ranging from single-cell organisms to advanced cancer tissue. The application areas include drug discovery and development and synthetic biology.
Intersection of biology and computer science
Bill Crowley, CEO of Crowley Davis Research and CFO of BioFi AG, commented: “The Basel Area is now home for this collection of proprietary technologies and quite fittingly so; the area is ground zero for exactly the kinds of talent and resources the company needs to achieve its highest and best use in science.” CEO of BioFi AG Thomas Nirnberger adds: “As one of the leading life sciences and technology clusters in Europe, the Basel Area is a natural location to grow a business at the intersection of biology and computer science.”
BioFi’s settlement has been supported by the location and innovation promotion agency Basel Area Business & Innovation and Switzerland Innovation.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
How Moderna is growing in Switzerland
The number one rule in real estate is “Location, Location, Location.” The global biotech company Moderna found its location in...
Read More
Sandoz decides on Basel for headquarters
Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected...
Read More
VectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...
Read More
University of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...
Read More
Rami Swiss and Elbit Systems now manufacturing in Jura
The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...
Read More
Basel to become Europe’s Silicon Valley of biotech
Silicon Valley is synonymous with technology and innovation, and home to dozens of Fortune 1000 companies and thousands of startups....
Read More
